Melperone (an Anti-Psychotic) in people with Psychosis Associated With Parkinson's Disease
This study is completed. It focuses on schizophrenia and currently lists study information in India, Italy, and the United States.
Schizophrenia, Parkinson's DiseaseDrug
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Melperone HCl may be useful for people experiencing schizophrenia.
What would participation involve?
Participants may receive Melperone HCl, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in India, in Italy, and in the United States.
Who is it mainly for?
This study appears to be mainly for people with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
India · 8 sites
Department of Neurology, Rajendra Prasad Ward, King George Hospital, Visakhapatnam
Visakhapatnam, Andhra Pradesh
Site status: Not listed — confirm with the team
Department of Neurology, Manipal Hospital
Bangalore, Karnataka
Site status: Not listed — confirm with the team
M. S. Ramasah Memorial Hospital
Bangalore, Karnataka
Site status: Not listed — confirm with the team
KLE Hospital, Belgaum
Belagavi, Karnataka
Site status: Not listed — confirm with the team
Kasturra Medical College, Hospital, Attavar
Mangalore, Karnataka
Site status: Not listed — confirm with the team
SCTIMST
Trivandrum, Kerla
Site status: Not listed — confirm with the team
Jaslok Hospital and Research Center
Mumbai, Maharashtra
Site status: Not listed — confirm with the team
Apollo Hospitals Educational and Research Foundation
Chennai, Tamil Nadu
Site status: Not listed — confirm with the team
Italy · 3 sites
Fondazione Universita di Chieti C.E.S.I. Centro Studi sull'Invecchiamento
Chieti Scalo, Ambruzzo
Site status: Not listed — confirm with the team
U.O. Neurologia IRCCS San Raffaele Pisana
Rome, Lazio
Site status: Not listed — confirm with the team
IRCCS Centro Neurolesi "Bonino Pulejo"
Messina, Sicily
Site status: Not listed — confirm with the team
United States · 10 sites
Northwest Neurospecialists, PLLC
Tucson, Arizona
Site status: Not listed — confirm with the team
Bradenton Research Center, Inc
Bradenton, Florida
Site status: Not listed — confirm with the team
University of South Florida
Tampa, Florida
Site status: Not listed — confirm with the team
The University of Kansas Medical Center
Kansas City, Kansas
Site status: Not listed — confirm with the team
Quest Research Institute
Bingham Farms, Michigan
Site status: Not listed — confirm with the team
Struthers Parkinson's Center, Park Nicollet Health Services
Golden Valley, Minnesota
Site status: Not listed — confirm with the team
Washington University School of Medicine
St Louis, Missouri
Site status: Not listed — confirm with the team
Neurology Consultants of the Carolinas
Charlotte, North Carolina
Site status: Not listed — confirm with the team
University of Cincinnati Medical Center
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Neurology Associates
San Antonio, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Melperone HCl, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Lundbeck LLC, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
